Steib 1998.
Methods | Randomized, placebo‐controlled trial | |
Participants | Liver transplant patients | |
Interventions | N‐acetylcysteine 150mg/kg bolus then, 50mg/kg for 4 hrs then 100mg/kg for 16 hrs versus placebo (dextrose 5%) | |
Outcomes | intraoperative haemodynamics and postoperative graft function | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Not‐stated, only says "(patients) were allocated randomly to be administered either NAC or, ... placebo". |
Allocation concealment (selection bias) | Unclear risk | Method of allocation to treatment group not stated. |
Blinding (performance bias and detection bias) All outcomes | Unclear risk | Blinding of treatment: not stated.
Blinding of assessor: not stated.
Blinding of data analysis: not stated. Probably not, as no indication of blinding in the manuscript. |
Selective reporting (reporting bias) | Low risk | |
Other bias | Low risk |